Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kahn SG and Actor P | Enhancement of sulfaquinoxaline activity by nystatin. | 1966 | Poult. Sci. | pmid:5962189 |
Kahn SG and Slocum A | Water miscible amphotericin for the treatment of crop mycosis in chicks. | 1966 | Poult. Sci. | pmid:5967855 |
Baum GL | Antifungal therapy, 1978. | 1979 | Postgrad Med J | pmid:392475 |
McRipley RJ et al. | Evaluation of vaginal antifungal formulations in vivo. | 1979 | Postgrad Med J | pmid:392480 |
Haller I | Modern aspects of testing azole antifungals. | 1979 | Postgrad Med J | pmid:392484 |
Holbrook WP and Kippax R | Sensitivity of Candida albicans from patients with chronic oral candidiasis. | 1979 | Postgrad Med J | pmid:392486 |
Grigoriu D et al. | Aspergillus sinusitis. | 1979 | Postgrad Med J | pmid:523351 |
Darisipudi MN et al. | Polyene macrolide antifungal drugs trigger interleukin-1β secretion by activating the NLRP3 inflammasome. | 2011 | PLoS ONE | pmid:21625424 |
Schulzke JD et al. | Anti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretion. | 2011 | PLoS ONE | pmid:21479205 |
Kalema N et al. | Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. | 2012 | PLoS ONE | pmid:22808020 |
Caliceti C et al. | Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. | 2012 | PLoS ONE | pmid:22859971 |
Siljamäki E et al. | Cholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway. | 2013 | PLoS ONE | pmid:23393580 |
ZemljiÄ Jokhadar Å et al. | Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell. | 2016 | PLoS ONE | pmid:27788169 |
Salyer AC et al. | Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. | 2016 | PLoS ONE | pmid:26919709 |
Kim HJ et al. | Post-PKS tailoring steps of a disaccharide-containing polyene NPP in Pseudonocardia autotrophica. | 2015 | PLoS ONE | pmid:25849545 |
Ono J et al. | Widespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common Environment. | 2017 | PLoS Biol. | pmid:28114370 |
Boyce ST and Holder IA | Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. | 1993 | Plast. Reconstr. Surg. | pmid:8341750 |
Margineanu C et al. | [The anticandida action of the saponine from Primula (author's transl)]. | 1976 | Planta Med. | pmid:785496 |
Gubler F et al. | Gibberellin signaling in barley aleurone cells. Control of SLN1 and GAMYB expression. | 2002 | Plant Physiol. | pmid:12011350 |
Sertié JA et al. | Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. | 2005 | Phytomedicine | pmid:15957367 |
Rosato A et al. | In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. | 2009 | Phytomedicine | pmid:19616925 |
Ahua KM et al. | Antileishmanial and antifungal acridone derivatives from the roots of Thamnosma rhodesica. | 2004 | Phytochemistry | pmid:15081302 |
Valitova JN et al. | Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. | 2011 | Phytochemistry | pmid:21726881 |
Joseph-Horne T et al. | Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. | 1996 | Phytochemistry | pmid:8768319 |
Dos Santos AG et al. | The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition. | 2017 | Phys Chem Chem Phys | pmid:29098221 |
Arrigoni-Martelli E et al. | The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema. | 1971 | Pharmacology | pmid:5088647 |
Wasan KM et al. | A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine. | 1999 | Pharm. Res. | pmid:9950297 |
Mohammadi G et al. | Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles. | 2017 | Pharm. Res. | pmid:27928646 |
Vermerie N et al. | Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. | 1997 | Pharm World Sci | pmid:9297733 |
Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
Silva FC et al. | Nystatin and lidocaine pastilles for the local treatment of oral mucositis. | 2017 | Pharm Dev Technol | pmid:27499389 |
Pinto Reis C et al. | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. | 2016 | Pharm Dev Technol | pmid:25567611 |
Wu J and Partridge LD | Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. | 1998 | Pflugers Arch. | pmid:9479023 |
Thodis E et al. | Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. | 1998 Nov-Dec | Perit Dial Int | pmid:9932656 |
Williams PF et al. | No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. | 2000 May-Jun | Perit Dial Int | pmid:10898060 |
Lye WC | Nystatin prophylaxis for fungal peritonitis: to be or not to be? | 2007 Sep-Oct | Perit Dial Int | pmid:17704437 |
Wong PN et al. | Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. | 2007 Sep-Oct | Perit Dial Int | pmid:17704443 |
Robitaille P et al. | Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. | 1995 | Perit Dial Int | pmid:7734569 |
Lo WK and Cheng IK | Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD? | 1999 Mar-Apr | Perit Dial Int | pmid:10357198 |
JAHN CL and CHERRY JD | CONGENITAL CUTANEOUS CANDIDIASIS. | 1964 | Pediatrics | pmid:14129091 |
Klein KC and Blackwood RA | Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. | 2006 | Pediatrics | pmid:16816005 |
Davis TC | Chronic vulvovaginitis in children due to Shigella flexneri. | 1975 | Pediatrics | pmid:1098002 |
Faix RG et al. | Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. | 1989 | Pediatrics | pmid:2909957 |
Cohen-Abbo A | Newborn with vesicular rash. Tinea corporis (tinea faciei). | 2000 | Pediatr. Infect. Dis. J. | pmid:10917228 |
Goins RA et al. | Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. | 2002 | Pediatr. Infect. Dis. J. | pmid:12506950 |
Hoppe JE | Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. | 1997 | Pediatr. Infect. Dis. J. | pmid:9076817 |
Spencer R et al. | Antimicrobial therapy for surgical diseases of the gastrointestinal tract. | 1968 | Pediatr. Clin. North Am. | pmid:5638370 |
Hildick-Smith G | Antifungal antibiotics. | 1968 | Pediatr. Clin. North Am. | pmid:4866900 |
Leibovitz E | Strategies for the prevention of neonatal candidiasis. | 2012 | Pediatr Neonatol | pmid:22503254 |
Hachiya KA et al. | Candida esophagitis following antibiotic usage. | 1982 May-Jun | Pediatr Infect Dis | pmid:7145730 |